Target intelligence / Profile preview

Plasmodium falciparum blood stage

Molecular classification
Other (protozoan parasite stage)
01

Overview

Plasmodium falciparum blood stage refers to the asexual and sexual developmental forms of the P. falciparum parasite residing inside human red blood cells. These stages include ring forms (trophozoites), mature trophozoites, schizonts (which release merozoites), and gametocytes (sexual forms for mosquito transmission)[2][1][3]. The blood stages are responsible for the clinical symptoms of malaria, including fever, anemia, and complications due to sequestration of infected cells in microvasculature. The parasite invades erythrocytes using highly specialized surface proteins and organelles, exhibiting complex mechanisms of immune evasion and red blood cell remodeling (e.g., through proteins like PfEMP1 and ligands such as Rh5 interacting with human Basigin (BSG))[2][5]. Because blood stages represent the symptomatic phase of malaria and include persister forms that may survive drug treatment[4], they are a central target for antimalarial drugs and vaccine development.

Other names
Blood stage P. falciparumErythrocytic stage Plasmodium falciparum
02

Mechanism of action

Inhibition of heme detoxification (e.g., chloroquine, quinine); Generation of reactive oxygen species (e.g., artemisinin derivatives); Inhibition of folate synthesis (pyrimethamine, sulfadoxine); Inhibition of mitochondrial electron transport (atovaquone); Inhibition of protein synthesis (doxycycline); Disruption of parasite membrane dynamics

03

Biological functions

Red blood cell invasionAsexual reproductionImmune system evasionPathogenesis of malariaGametocyte formation
04

Disease associations

InfectionMalaria
05

Safety considerations

Rapid emergence of drug resistancePossibility of recrudescence from dormant persister forms (notably after artemisinin treatment)Potential drug toxicity to host cells (especially hemolysis in G6PD-deficient individuals with primaquine)Difficulty in distinguishing between viable and dead blood stage parasites after therapy
06

Interacting drugs

Artesunate

9 more in the full profile.

07

Biomarkers

Detection of circulating parasite DNA/RNADetection of HRP2 antigen (histidine-rich protein 2) in rapid diagnostic testsDetection of lactate dehydrogenase specific to P. falciparumGametocyte markers in molecular assays

Beyond the preview

Go deeper on Plasmodium falciparum blood stage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum blood stage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call